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Acute SIV infection of macaques is a model for human
AIDS typified by high levels of plasma viremia that
decline with the onset of specific viral immunity. SIV
infection limits the development of viral immunity and
persists to allow for the establishment of chronic progres-
sive disease. The destruction of CD4+ and CD4- lym-
phocytes argues that both direct and indirect killing
mechanisms contribute to the loss of cells. Although early
intervention with antiretroviral drugs reduces viremia and
disease, it is still unclear whether protection is due to
diminished viral cytopathicity or due to blocking a host
mechanism for cell killing that is triggered by the high
level of viral replication. We tested the role of FasL killing
of bystander lymphocytes by injecting monkeys with a
humanized monoclonal anti-FasL. Treatment with anti-
FasL during acute infection reduced the level of apoptosis
of circulating T and B cells, peak vRNA levels were unaf-
fected but higher antibody and CTL responses to viral pro-
teins lead to lower set-point viremia among treated
macaques. Reduced bystander killing and increased viral
immunity were associated with attenuated SIV disease
and a significant increase in the life span of infected
macaques after transient treatment with a monoclonal
antibody against FasL.
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